| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 4/6 |
| Past Performance | 0/6 |
| Financial Health | 4/6 |
| Dividends | 1/6 |
Zhejiang Garden Biopharmaceutical Co.,Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CN¥15.18 |
| 52 Week High | CN¥15.56 |
| 52 Week Low | CN¥7.58 |
| Beta | 0.033 |
| 11 Month Change | 28.32% |
| 3 Month Change | 47.38% |
| 1 Year Change | 30.64% |
| 33 Year Change | 18.97% |
| 5 Year Change | -13.21% |
| Change since IPO | 652.23% |
Recent News & Updates
Why Investors Shouldn't Be Surprised By Zhejiang Garden Biopharmaceutical Co.,Ltd.'s (SZSE:300401) 27% Share Price Surge
Jun 30
Is Zhejiang Garden BiopharmaceuticalLtd (SZSE:300401) A Risky Investment?
May 31Recent updates
Why Investors Shouldn't Be Surprised By Zhejiang Garden Biopharmaceutical Co.,Ltd.'s (SZSE:300401) 27% Share Price Surge
Jun 30Is Zhejiang Garden BiopharmaceuticalLtd (SZSE:300401) A Risky Investment?
May 31Subdued Growth No Barrier To Zhejiang Garden Biopharmaceutical Co.,Ltd. (SZSE:300401) With Shares Advancing 27%
May 06Why Zhejiang Garden BiopharmaceuticalLtd's (SZSE:300401) Shaky Earnings Are Just The Beginning Of Its Problems
Apr 22Shareholder Returns
| 300401 | CN Pharmaceuticals | CN Market | |
|---|---|---|---|
| 7D | 20.1% | -0.1% | 0.4% |
| 1Y | 30.6% | -15.9% | -17.8% |
Return vs Industry: 300401 exceeded the CN Pharmaceuticals industry which returned -17.3% over the past year.
Return vs Market: 300401 exceeded the CN Market which returned -17.9% over the past year.
Price Volatility
| 300401 volatility | |
|---|---|
| 300401 Average Weekly Movement | 8.4% |
| Pharmaceuticals Industry Average Movement | 5.5% |
| Market Average Movement | 6.7% |
| 10% most volatile stocks in CN Market | 10.1% |
| 10% least volatile stocks in CN Market | 4.2% |
Stable Share Price: 300401's share price has been volatile over the past 3 months.
Volatility Over Time: 300401's weekly volatility (8%) has been stable over the past year, but is still higher than 75% of CN stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2000 | 943 | Huanzheng Ma | www.hybiotech.com |
Zhejiang Garden Biopharmaceutical Co.,Ltd. manufactures and supplies lanolin cholesterol, vitamin D3, 25-hydroxyvitamin D3, and refined lanolin products in China. It offers cholesterol; feed grade cholesterol; food additives compound nutrient fortifier SDS, CO, and MO; cholecalciferol; feed additive - vitamin D3 particles and oil; VD3 resin oil; 25 hydroxyvitamin D3 progen and powder; 25 hydroxyvitamin D3; anhydrous lanolin; wood oil; wool wax; low chroma pure fat; lanolin alcohol; isopropyl lanolate; lanolinic acid; high acid fat; wood acid biofuel/wood alcohol biofuel; and rodenticide made from Vitamin D3.
Zhejiang Garden Biopharmaceutical Co.,Ltd. Fundamentals Summary
| 300401 fundamental statistics | |
|---|---|
| Market cap | CN¥8.09b |
| Earnings (TTM) | CN¥231.97m |
| Revenue (TTM) | CN¥1.11b |
34.9x
P/E Ratio7.3x
P/S RatioIs 300401 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 300401 income statement (TTM) | |
|---|---|
| Revenue | CN¥1.11b |
| Cost of Revenue | CN¥456.75m |
| Gross Profit | CN¥651.05m |
| Other Expenses | CN¥419.08m |
| Earnings | CN¥231.97m |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
Aug 24, 2024
| Earnings per share (EPS) | 0.44 |
| Gross Margin | 58.77% |
| Net Profit Margin | 20.94% |
| Debt/Equity Ratio | 52.4% |
How did 300401 perform over the long term?
See historical performance and comparison